Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolismTing Ni, Libin Wei|Cell Death and Disease|2017Cited by 87
RETRACTED ARTICLE: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progressionLibin Wei, Lin Yang|Cell Death and Disease|2017Cited by 70
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cellsKai Zhao, Libin Wei|Journal of Hematology & Oncology|2015Cited by 67
Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signalingJingyue Yao, Libin Wei|Acta Pharmacologica Sinica|2021Cited by 51
Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumorLibin Wei, Na Lu|Oncotarget|2015Cited by 41